Examination of Glutamate and mGluR5 in Psychiatric Disorders
Diseases of the Nervous System | Mental Health & Behavioral Research
What is the purpose of this trial?
This research study is designed to look at the involvement of the glutamate system in depression. Each subject will undergo a screening appointment to determine study eligibility. Thereafter, the study will take 2 or 3 visits depending on schedule availability and will consist of one MRI scan, and PET scan. Subjects will also participate in cognitive testing. Depending on camera time, staff availability and subject schedule, total study participation may last 1-2 months.
- Ages18 years - 65 years
- Trial withYale University School of Medicine
- Start Date08/23/2011
- End Date08/22/2021
- Last Updated07/15/2021
- Study HIC#1101007933